Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Surg ; 49(1): 46-49; discussion 49-50, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24439579

ABSTRACT

PURPOSE: Cardiac or major vascular perforation is a rare but serious risk of ECMO. We sought to determine if perforation rates are related to cannula design. METHODS: We utilized three methods to evaluate perforation on ECMO. 1. The ELSO registry was queried to establish the historical rate of hemorrhagic pericardial tamponade. 2. ELSO centers were surveyed regarding cannula related perforation events and brands of cannulas used over a four year time period (January 2008-March 2012). 3. The FDA's MAUDE database was reviewed looking for adverse events related to ECMO cannulas. RESULTS: The historical rate of hemorrhagic pericardial tamponade in the ELSO registry was 0.53% (~1985-2010, ELSO registry). In the survey there were eleven reports of cannula-related perforation, 0.74% (11/1482 p-value=0.29) at 7 different ELSO centers with 23 ELSO centers responding (17% response rate). The incidence of perforation was much higher for the wire-reinforced bicaval design 3.6% (10/279) as compared to catheters designed for the atrial position, 0.1% (1/1203, p-value<0.0001). Review of the FDA's MAUDE database revealed 19 adverse events related to the bicaval cannula design, 16 of which were hemorrhagic pericardial effusions or tamponade. CONCLUSION: These findings suggest a relatively high rate of cardiac perforation associated with the dual lumen bicaval cannula. This may be related to inherent differences in cannula design or the IVC positioning required by the design.


Subject(s)
Cardiac Tamponade/etiology , Catheters , Extracorporeal Membrane Oxygenation/adverse effects , Extracorporeal Membrane Oxygenation/instrumentation , Heart Injuries/etiology , Vena Cava, Superior/injuries , Adult , Child , Databases, Factual , Equipment Design , Health Care Surveys , Heart Atria/injuries , Heart Injuries/prevention & control , Hemorrhage/etiology , Humans , Infant, Newborn , Radiography, Interventional/methods , Registries , Retrospective Studies , Risk
2.
J Pediatr Surg ; 49(1): 104-7; discussion 108, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24439591

ABSTRACT

BACKGROUND: Since its introduction as an alternative intestinal lengthening technique, serial transverse enteroplasty (STEP) has been increasingly used as the surgical treatment of choice for patients with refractory short bowel syndrome (SBS). While primary STEP for the treatment of congenital conditions was proposed in the original description of the procedure, emphasis was placed on a delayed or staged approach to these patients. To date, a comprehensive review of the outcomes from this sub-population has not been reported by the International STEP Data Registry. METHODS: A retrospective review of the International STEP Data Registry was performed to identify all patients who underwent STEP as a primary operative procedure for the treatment of congenital SBS. Changes in pre- and post-STEP values were assessed using paired t-tests with significance set at p<0.05. Data are presented as mean ± standard deviation. RESULTS: Fifteen patients underwent primary STEP for congenital SBS between September 1, 2004, and April 10, 2012. Thirteen patients had follow-up information available. Causes of congenital SBS included closing gastroschisis, small bowel atresia, and midgut volvulus. Twelve patients had pre- and post-STEP bowel measurements taken. Average pre- and post-STEP bowel lengths were 32 ± 16 cm and 47 ± 22 cm, respectively. Intestinal length was increased by a mean of 15 ± 12 cm for a relative small bowel length increase of 50.4 ± 27.3% (p<0.001). Only one patient required an ostomy at the time of primary STEP. A second patient required a temporary ostomy at 3months of age that was later closed. There was one death from intestinal failure associated liver disease (IFALD). Another patient experienced IFALD progression and required liver and intestinal transplantation. The most commonly reported complication following primary STEP was obstruction or bowel re-dilatation requiring additional operative interventions. Nine patients underwent second STEP procedures under these circumstances. Eight patients remain dependent on parenteral nutrition, while three patients achieved enteral autonomy. CONCLUSIONS: Primary STEP is a feasible and safe surgical option for the treatment of congenital conditions resulting in SBS. Primary STEP establishes early bowel continuity, creates intestinal length from congenitally dilated bowel, and appears to obviate the need for interval stomas and their associated loss of bowel length in neonates with congenital SBS. However, with recent changes in SBS management emphasizing intestinal rehabilitation, additional studies are needed to assess the long-term impact on intestinal adaptation of STEP performed in the neonatal period prior to adoption of this technique.


Subject(s)
Intestine, Small/abnormalities , Intestine, Small/surgery , Short Bowel Syndrome/surgery , Tissue Expansion/methods , Follow-Up Studies , Gastroschisis/complications , Gestational Age , Humans , Infant, Newborn , Intestinal Atresia/complications , Intestinal Volvulus/complications , Liver Failure/epidemiology , Liver Failure/surgery , Liver Transplantation , Ostomy/statistics & numerical data , Parenteral Nutrition/statistics & numerical data , Postoperative Complications/epidemiology , Registries , Retrospective Studies , Short Bowel Syndrome/etiology , Treatment Outcome
4.
J Pediatr Surg ; 48(5): E33-6, 2013 May.
Article in English | MEDLINE | ID: mdl-23701806

ABSTRACT

We document a previously unreported case of a pulmonary artery pseudoaneurysm (PAP) that developed in a pediatric patient initially presenting with Methicillin-resistant Staphylococcus aureus hip joint sepsis. This is the first reported case of PAP of infectious origin in a pediatric patient, and this case is unique as the evolution of the PAP was documented by computed tomography.


Subject(s)
Aneurysm, False/diagnostic imaging , Arthritis, Infectious/complications , Bacteremia/complications , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Multidetector Computed Tomography , Pulmonary Artery/diagnostic imaging , Staphylococcal Infections/complications , Aneurysm/diagnosis , Aneurysm, False/etiology , Aneurysm, False/surgery , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/drug therapy , Arthritis, Infectious/microbiology , Arthritis, Infectious/surgery , Bacteremia/drug therapy , Bacteremia/microbiology , Chest Tubes , Child , Combined Modality Therapy , Contraindications , Diagnosis, Differential , Drainage , Embolization, Therapeutic , Empyema, Pleural/etiology , Empyema, Pleural/microbiology , Hemoptysis/etiology , Hip Joint/microbiology , Hip Joint/surgery , Humans , Male , Pneumonectomy/methods , Pneumothorax/etiology , Pneumothorax/surgery , Pulmonary Artery/surgery , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/etiology , Pulmonary Embolism/microbiology , Pulmonary Embolism/surgery , Reoperation , Respiratory Distress Syndrome/etiology , Staphylococcal Infections/diagnostic imaging , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Staphylococcal Infections/surgery , Thoracotomy
5.
Hawaii J Med Public Health ; 71(6): 158-62, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22787564

ABSTRACT

Chilaiditi syndrome is a rare condition defined by the presence of gastrointestinal symptoms associated with the radiological finding of segmental interposition of the bowel between the liver and the diaphragm. While it is infrequently indentified as a source of abdominal pain, Chilaiditi syndrome carries clinical significance as it can lead to a number of serious complications including intestinal obstruction, perforation, and ischemia. A 58-year-old woman presented with Chilaiditi syndrome immediately following colonoscopic evaluation. Conservative measures failed to alleviate the patient's symptoms, and the patient ultimately elected to have operative management. Pexy of the cecum and ascending colon led to full resolution of her symptoms. To our knowledge, this is the first documented case of Chilaiditi syndrome iatrogenically induced by colonoscopy. Identification of this syndrome as a complication of colonoscopy and a source of post-procedural pain bears significance for providers involved in the peri-operative care of patients with factors predisposing them to the development of this condition.


Subject(s)
Chilaiditi Syndrome/etiology , Colonoscopy/adverse effects , Female , Humans , Middle Aged , Postoperative Complications , Reoperation
SELECTION OF CITATIONS
SEARCH DETAIL
...